Non-invasive imaging of vascular inflammation

Frontiers in Immunology

Volumn 5, Issue AUG, 2014, Pages

  Ammirati, Enrico ^a,b   Moroni, Francesco ^a   Pedrotti, Patrizia ^b   Scotti, Isabella ^a   Magnoni, Marco ^a   Bozzolo, Enrica P ^a   Rimoldi, Ornella E ^a,c   Camici, Paolo G ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c INSTITUTE OF MOLECULAR BIOIMAGING AND PHYSIOLOGY   (Italy)

Author keywords

Cardiovascular magnetic resonance; Contrast enhanced ultrasound; Non invasive imaging; Positron emission tomography; Vascular inflammation; Vasculitis

Indexed keywords

EID: 84937436560     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00399     Document Type: Article

References (136)

1. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 Revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum (2013) 65(1):1-11. doi:10.1002/art.37715.
2. Miller A, Chan M, Wiik A, Misbah SA, Luqmani RA. An approach to the diagnosis and management of systemic vasculitis. Clin Exp Immunol (2010) 160(2):143-60. doi:10.1111/j.1365-2249.2009.04078.x.
3. Pipitone N, Versari A, Hunder GG, Salvarani C. Role of imaging in the diagnosis of large and medium-sized vessel vasculitis. Rheum Dis Clin North Am (2013) 39(3):593-608. doi:10.1016/j.rdc.2013.02.002.
4. Weyand CM, Goronzy JJ. Medium- and large-vessel vasculitis. N Engl J Med (2003) 349(2):160-9. doi:10.1056/NEJMra022694.
5. Mason JC. Takayasu arteritis - advances in diagnosis and management. Nat RevRheumatol (2010) 6(7):406-15. doi: 10.1038/nrrheum.2010.82.
6. Ishikawa K. Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasu's arteriopathy. J Am Coll Cardiol (1988) 12(4):964-72. doi:10.1016/0735-1097(88)90462-7.
7. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum (1990) 33(8):1129-34. doi:10.1002/art.1780330811.
8. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum (1990) 33(8):1122-8. doi:10.1002/art. 1780330810.
9. Alibaz-Oner F, Aydin SZ, Direskeneli H. Advances in the diagnosis, assessment and outcome of Takayasu's arteritis. Clin Rheumatol (2013) 32(5):541-6. doi:10.1007/s10067-012-2149-3
10. Smetana GW, Shmerling RH. Does this patient have temporal arteritis? JAMA (2002) 287(1):92-101. doi:10.1001/jama.287.1.92
11. Watts R, Al-Taiar A, Mooney J, Scott D, Macgregor A. The epidemiology of Takayasu arteritis in the UK. Rheumatology (2009) 48(8):1008-11. doi:10.1093/rheumatology/kep153.
12. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, etal. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis (2009) 68(3):318-23. doi:10.1136/ard.2008. 088351.
13. Mavrogeni S, Papadopoulos G, Karanasios E, Cokkinos DV. How to image Kawasaki disease: a validation of different imaging techniques. Int J Cardiol (2008) 124(1):27-31. doi:10.1016/j.ijcard.2007.02.035
14. Schmidt WA. Use of imaging studies in the diagnosis of vasculitis. Curr Rheumatol Rep (2004) 6(3):203-1 1. doi:10.1007/s1 1926-004-0069-1
15. Numano F. Vasa vasoritis, vasculitis and atherosclerosis. IntJ Cardiol (2000) 75(Suppl 1):S1-8. discussion S17-9.
16. Mulligan-Kehoe MJ. The vasa vasorum in diseased and nondiseased arteries. AmJPhysiolHeart Circ Physiol (2010) 298(2):H295-305. doi:10.1152/ajpheart. 00884.2009
17. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb VascBiol (2012) 32(9):2045-51.doi:10.1161/ATVBAHA.108.179705
18. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation (2002) 105(9):1 135-43. doi:10.1161/hc0902.104353
19. Sanz J, Fayad ZA. Imaging of atherosclerotic cardiovascular disease. Nature (2008) 451(7181):953-7. doi:10.1038/nature06803
20. Skaggs BJ, Hahn BH, McMahon M. Accelerated atherosclerosis in patients with SLE - mechanisms and management. Nat Rev Rheumatol (2012) 8(4) :214-23. doi:10.1038/nrrheum.2012.14
21. Gkaliagkousi E, Gavriilaki E, Doumas M, Petidis K, Aslanidis S, Stella D. Cardiovascular risk in rheumatoid arthritis: pathogenesis, diagnosis, and management. J Clin Rheumatol (2012) 18(8):422-30. doi:10.1097/RHU. 0b013e31827846b1
22. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum (2001) 44(10):2331-7. doi:10.1002/1529-0131(200110)44:10<2331::AID-ART395> 3.0.CO;2-I
23. Camici PG, Rimoldi OE, Gaemperli O, Libby P. Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque. Eur Heart J (2012) 33(11):1309-17. doi:10.1093/eurheartj/ehs067
24. Ammirati E, Magnoni M, Camici PG. Need for new non-invasive imaging strategies to identify high-risk asymptomatic patients with carotid stenosis. Int J Cardiol (2013) 168(4):4342-3. doi:10.1016/j.ijcard.2013.05.079
25. Schmidt WA, Gromnica-Ihle E. What is the best approach to diagnosing large-vessel vasculitis? Best Pract Res Clin Rheumatol (2005) 19(2):223-42. doi:10.1016/j.berh.2005.01.006
26. Schmidt WA, Backhaus M. What the practising rheumatologist needs to know about the technical fundamentals of ultrasonography. Best Pract Res Clin Rheumatol (2008) 22(6):981-99. doi:10.1016/j.berh.2008.09.013
27. Zierler RE, Beach KW, Bergelin RO, Lal BK, Moore WS, Roubin GS, et al. Agreement between site-reported and ultrasound core laboratory results for duplex ultrasound velocity measurements in the carotid revascularization endarterectomyversus stenting trial.JVascSurg (2014) 59(1):2-7. doi:10.1016/j.jvs.2013. 06.071
28. De Miguel E, Castillo C, Rodriguez A, De Agustin JJ. Working Group Ultrasound Giant Cell Arteritis. Learning and reliability of colour Doppler ultrasound in giant cell arteritis. Clin Exp Rheumatol (2009) 27(1 Suppl 52):S53-8.
29. Schmidt WA, Kraft HE, Vorpahl K, Volker L, Gromnica-Ihle EJ. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med (1997) 337(19):1336-42. doi:10.1056/NEJM199711063371902
30. Karassa FB, Matsagas MI, Schmidt WA, Ioannidis JP. Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med (2005) 142(5):359-69.doi:10.7326/0003-4819-142-5-200503010-00011
31. Arida A, Kyprianou M, Kanakis M, Sfikakis PP. The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis. BMC Musculoskelet Disord (2010) 11:44. doi:10.1186/1471-2474-11-44
32. Ball EL, Walsh SR, Tang TY, Gohil R, Clarke JM. Role of ultrasonography in the diagnosis of temporal arteritis. Br J Surg (2010) 97(12):1765-71. doi:10.1002/bjs.7252
33. Ghinoi A, Pipitone N, Nicolini A, Boiardi L, Silingardi M, Germano G, et al. Large-vessel involvement in recent-onset giant cell arteritis: a casecontrol colour-Doppler sonography study. Rheumatology (2012) 51(4):730-4. doi:10.1093/rheumatology/ker329
34. Aschwanden M, Kesten F, Stern M, Thalhammer C, Walker UA, Tyndall A, et al. Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions. Ann Rheum Dis (2010) 69(7):1356-9. doi:10.1136/ard.2009.122135
35. Diamantopoulos AP, Haugeberg G, Hetland H, Soldal DM, Bie R, Myklebust G. Diagnostic value of color Doppler ultrasonography of temporal arteries and large vessels in giant cell arteritis: a consecutive case series. Arthritis Care Res (Hoboken) (2014) 66(1):113-9. doi:10.1002/acr.22178
36. Schmidt WA, Seifert A, Gromnica-Ihle E, Krause A, Natusch A. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in largevessel giant cell arteritis. Rheumatology (2008) 47(1):96-101. doi:10.1093/ rheumatology/kem322
37. MaedaH,HandaN, Matsumoto M, Hougaku H, OgawaS, Oku N,et al. Carotid lesions detected by B-mode ultrasonography in Takayasu's arteritis: "macaroni sign" as an indicator of the disease. Ultrasound Med Biol (1991) 17(7):695-701. doi:10.1016/0301-5629(91)90101-2
38. Reinhard M, Schmidt D, Hetzel A. Color-coded sonography in suspected temporal arteritis-experiences after 83 cases. Rheumatol Int (2004) 24(6):340-6. doi:10.1007/s00296-003-0372-6
39. Habib HM, Essa AA, Hassan AA. Color duplex ultrasonography of temporal arteries: role in diagnosis and follow-up of suspected cases of temporal arteritis. Clin Rheumatol (2012) 31(2):231-7. doi:10.1007/s10067-011-1808-0
40. Keo HH, Caliezi G, Baumgartner I, Diehm N, Willenberg T. Increasing echogenicity of diffuse circumferential thickening ("macaroni sign") of the carotid artery wall with decreasing inflammatory activity of Takayasu arteritis. JClin Ultrasound (2013) 41(1):59-62. doi:10.1002/jcu.20894
41. Nambi V, Chambless L, Folsom AR, He M, Hu Y, Mosley T, et al. Carotid intimamedia thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (atherosclerosis risk in communities) study. J Am Coll Cardiol (2010) 55(15):1600-7. doi:10.1016/S0735-1097(10) 61285-5
42. Tyrrell PN, Beyene J, Feldman BM, McCrindle BW, Silverman ED, Bradley TJ. Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis. Arterioscler Thromb VascBiol (2010) 30(5): 1014-26. doi:10.1161/ATVBAHA.109.198424
43. Ammirati E, Bozzolo EP, Contri R, Baragetti A, Palini AG, Cianflone D, et al. Cardiometabolic and immune factors associated with increased common carotid artery intima media thickness and cardiovascular disease in patients with systemic lupus erythematosus. NutrMetab CardiovascDis (2014) 24(7):751-9. doi:10.1016/j.numecd.2014.01.006
44. de Jong N, Bouakaz A, Frinking P. Basic acoustic properties of microbubbles. Echocardiography (2002) 19(3):229-40.doi:10.1046/j.1540-8175.2002.00229.x
45. Kono Y, Pinnell SP, Sirlin CB, Sparks SR, Georgy B, Wong W, et al. Carotid arteries: contrast-enhanced US angiography - preliminary clinical experience. Radiology (2004) 230(2):561-8. doi:10.1148/radiol.2302020318
46. Coli S, Magnoni M, Sangiorgi G, Marrocco-Trischitta MM, Melisurgo G, Mauriello A, et al. Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity. JAm Coll Cardiol (2008) 52(3):223-30. doi:10.1016/j.jacc.2008.02.082
47. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol (2005) 25(10):2054-61.doi:10.1161/01.ATV.0000178991.71605.18
48. Giordana P, Baque-Juston MC, Jeandel PY, Mondot L, Hirlemann J, Padovani B, et al. Contrast-enhanced ultrasound of carotid artery wall in Takayasu disease: first evidence of application in diagnosis and monitoring of response to treatment. Circulation (2011) 124(2):245-7. doi:10.1161/CIRCULATIONAHA. 110.006668
49. Magnoni M, Dagna L, Coli S, Cianflone D, Sabbadini MG, Maseri A. Assessment of Takayasu arteritis activity by carotid contrast-enhanced ultrasound. Circ Cardiovasc Imaging (2011) 4(2):e1-2. doi:10.1161/CIRCIMAGING.110. 960906
50. Schinkel AF, van den Oord SC, van der Steen AF, van Laar JA, Sijbrands EJ. Utility of contrast-enhanced ultrasound for the assessment of the carotid artery wall in patients with Takayasu or giant cell arteritis. Eur Heart J Cardiovasc Imaging (2013) 15(5):541-6. doi:10.1093/ehjci/jet243
51. Villanueva FS. Molecular imaging of cardiovascular disease using ultrasound. JNucl Cardiol (2008) 15(4):576-86. doi:10.1016/j.nuclcard.2008.05.005
52. Villanueva FS, Wagner WR. Ultrasound molecular imaging of cardiovascular disease. Nat Clin Pract Cardiovasc Med (2008) 5(Suppl 2):S26-32. doi: 10.1038/ncpcardio 1246
53. Barger AC, Beeuwkes R III, Lainey LL, Silverman KJ. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med (1984) 310(3):175-7. doi:10.1056/NEJM198401193100307
54. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, et al. Intraplaque hemorrhage and progression of coronary atheroma. N EnglJ Med (2003) 349(24):2316-25. doi:10.1056/NEJMoa035655
55. Shah F, Balan P, Weinberg M, Reddy V, Neems R, Feinstein M, et al. Contrastenhanced ultrasound imaging of atherosclerotic carotid plaque neovascularization: a new surrogate marker of atherosclerosis? Vasc Med (2007) 12(4):291-7. doi:10.1177/1358863X07083363
56. Prabhu M, Raju D, Pauli H. Transesophageal echocardiography: instrumentation and system controls. Ann Card Anaesth (2012) 15(2):144-55. doi:10.4103/ 0971-9784.95080
57. Moortgat S, Tuerlinckx D, Bodart E, El Khoury G, Moniotte S. Severe ostial stenosis of the left coronary artery in a 12-year-old girl as the first manifestation of Takayasu's arteritis. Acta Cardiol (2009) 64(6):825-9. doi:10.2143/AC. 64.6.2044753
58. Kopterides P, Moyssakis I, Margos P, Sipsas NV. Echocardiographic findings in patients with temporal arteritis: apropos of one case of temporal arteritisassociatedverrucous( Libman-Sachs) endocarditis. Clin Exp Rheumatol (2006) 24(2Suppl41):S35-7.
59. Nakao M, Ong KK, Lim YP, Wong KY. Aortic intimal fold in Takayasu arteritis causing obstruction of left coronary ostium. Pediatr Cardiol (2011) 32(7):990-2. doi:10.1007/s00246-011-0023-8
60. Bezerra Lira-Filho E, Campos O, Lazaro Andrade J, Henrique Fischer C, Godoy Nunes C, Cavalcanti Lins A, et al. Thoracic aorta evaluation in patients with Takayasu's arteritis by transesophageal echocardiography. J Am Soc Echocardiogr (2006) 19(6):829-34. doi:10.1016/j.echo.2005.12.023
61. Espinola-Zavaleta N, Soto ME, Bauk L, Miguel Casanova J, Keirns C, Avila Vanzzini N, et al. Coronary reserve in Takayasu's arteritis: transesophageal echocardiographic analysis. Echocardiography (2005) 22(7):593-8. doi:10. 1111/j.1540-8175.2005.40105.x
62. Valente F, Carro A, Moral S, Evangelista A. Multiple thrombi in the ascending aorta usefulness of contrast transesophageal echocardiography in a case of Horton's aortitis. Circulation (2013) 128(3):e44-5. doi:10.1161/ CIRCULATIONAHA.1 12.001156
63. Kissin EY, Merkel PA. Diagnostic imaging in Takayasu arteritis. Curr Opin Rheumatol (2004) 16(1):31-7. doi:10.1097/00002281-200401000-00007
64. Gotway MB, Araoz PA, Macedo TA, Stanson AW, Higgins CB, Ring EJ, et al. Imaging findings in Takayasu's arteritis. Am J Roentgenol (2005) 184(6):1945-50. doi:10.2214/ajr.184.6.01841945
65. Khandelwal N, Kalra N, Garg MK, Kang M, Lal A, Jain S, et al. Multidetector CT angiography in Takayasu arteritis. Eur J Radiol (2011) 77(2):369-74. doi:10.1016/j.ejrad.2009.08.001
66. Yoshida S, Akiba H, Tamakawa M, Yama N, Takeda M, Hareyama M, et al. The spectrum of findings in supra-aortic Takayasu's arteritis as seen on spiral CT angiography and digital subtraction angiography. Cardiovasc Intervent Radiol (2001) 24(2):117-21. doi:10.1007/s002700000368
67. Matsunaga N, Hayashi K, Sakamoto I, Ogawa Y, Matsumoto T. Takayasu arteritis: protean radiologic manifestations and diagnosis. Radiographics (1997) 17(3):579-94. doi:10.1148/radiographics.17.3.9153698
68. Park JH, Chung JW, Im JG, Kim SK, Park YB, Han MC. Takayasu arteritis: evaluation of mural changes in the aorta and pulmonary artery with CT angiography. Radiology (1995) 196(1):89-93. doi:10.1148/radiology.196.1.7784596
69. Chung JW, Kim HC, Choi YH, Kim SJ, Lee W, Park JH. Patterns of aortic involvement in Takayasu arteritis and its clinical implications: evaluation with spiral computed tomography angiography. J Vasc Surg (2007) 45(5):906-14. doi:10.1016/j.jvs.2007.01.016
70. Paul JF, Fiessinger JN, Sapoval M, Hernigou A, Mousseaux E, Emmerich J, et al. Follow-up electron beam CT for the management of early phase Takayasu arteritis. JComputAssist Tomogr (2001) 25(6):924-31. doi:10.1097/00004728-200111000-00015
71. Yamada I, Nakagawa T, Himeno Y, Numano F, Shibuya H. Takayasu arteritis: evaluation of the thoracic aorta with CT angiography. Radiology (1998) 209(1):103-9. doi:10.1148/radiology.209.1.9769819
72. Kang EJ, Kim SM, Choe YH, Lee GY, Lee KN, Kim DK. Takayasu arteritis: assessment of coronary arterial abnormalities with 128-section dual-source CT angiography of the coronary arteries and aorta. Radiology (2014) 270( 1 ):74-81. doi: 10.1148/radiol. 13122195
73. Prieto-Gonzalèz S, Arguis P, Garcia-Martinez A, Espigol-Frigole G, Tavera-Bahillo I, Butjosa M, et al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis (2012) 71(7):1170-6. doi:10.1136/annrheumdis-2011-200865
74. Weber DA, Ivanovic M. Correlative image registration. Semin Nucl Med (1994) 24(4):311-23. doi:10.1016/S0001-2998(05)80021-2
75. Gaemperli O, Boyle JJ, Rimoldi OE, Mason JC, Camici PG. Molecular imaging of vascular inflammation. Eur J Nucl Med Mol Imaging (2010) 37(6):1236. doi:10.1007/s00259-009-1371-y
76. Weber WA, Grosu AL, Czernin J. Technology insight: advances in molecular imaging and an appraisal of PET/CT scanning. Nat Clin Pract Oncol (2008) 5(3):160-70. doi:10.1038/ncponc1041
77. Ishimori T, Saga T, Mamede M, Kobayashi H, Higashi T, Nakamoto Y, et al. Increased (18)F-FDG uptake in a model of inflammation: concanavalin Amediated lymphocyte activation. JNucl Med (2002) 43(5):658-63.
78. Meller J, Strutz F, Siefker U, Scheel A, Sahlmann CO, Lehmann K, et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging (2003) 30(5):730-6. doi:10.1007/s00259-003-1144-y
79. Belhocine T, Blockmans D, Hustinx R, Vandevivere J, Mortelmans L. Imaging of large vessel vasculitis with (18)FDGPET: illusion or reality? A critical review of the literature data. Eur J Nucl Med Mol Imaging (2003) 30(9):1305-13. doi:10.1007/s00259-003-1209-y
80. Hautzel H, Sander O, Heinzel A, Schneider M, Muller HW. Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio. J Nucl Med (2008) 49(7):1107-13. doi:10.2967/jnumed.108.051920
81. Besson FL, Parienti JJ, Bienvenu B, Prior JO, Costo S,BouvardG, et al. Diagnostic performance of (1)(8)F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis. Eur J Nucl Med MolImaging (2011) 38(9):1764-72. doi:10.1007/s00259-011-1830-0
82. Lehmann P, Buchtala S, Achajew N, Haerle P, Ehrenstein B, Lighvani H, et al. 18F-FDG PET as a diagnostic procedure in large vessel vasculitis-a controlled, blinded re-examination of routine PET scans. Clin Rheumatol (2011)30(1):37-42. doi:10.1007/s10067-010-1598-9
83. Walter MA. [(18)F]fluorodeoxyglucose PET in large vessel vasculitis. Radiol Clin North Am (2007) 45(4):735-44, viii. doi:10.1016/j.rcl.2007.05.012
84. Henes JC, Muller M, Krieger J, Balletshofer B, Pfannenberg AC, Kanz L, et al. [18F] FDG-PET/CT as a new and sensitive imaging method for the diagnosis of large vessel vasculitis. Clin Exp Rheumatol (2008) 26(3 Suppl 49): S47-52.
85. Kobayashi Y, Ishii K, Oda K, Nariai T, Tanaka Y, Ishiwata K, et al. Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDGPETcoregistered with enhanced CT. JNuclMed (2005) 46(6):917-22.
86. Rehak Z, Szturz P, Kren L, Fojtik Z, Stanicek J. Upsampling from aorta and aortic branches: PET/CT hybrid imaging identified 18F-FDG hypermetabolism in inflamed temporal and occipital arteries. Clin Nucl Med (2014) 39(1):e84-6. doi:10.1097/RLU.0b013e3182868aae
87. Fuchs M, Briel M, Daikeler T, Walker UA, Rasch H, Berg S, et al. The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging (2012) 39(2):344-53. doi:10.1007/s00259-011-1967-x
88. Blockmans D, de Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum (2006) 55(1):131-7. doi:10.1002/art.21699
89. Cheng Y, Lv N, Wang Z, Chen B, Dang A. 18-FDG-PET in assessing disease activity in Takayasu arteritis: a meta-analysis. Clin Exp Rheumatol (2013) 31(1 Suppl 75):S22-7.
90. Blockmans D, Coudyzer W, Vanderschueren S,Stroobants S, LoeckxD, Heye S, et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology (2008) 47(8):1179-84. doi:10.1093/rheumatology/ken119
91. Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapere JJ, Lindemann P, et al. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci (2006) 27(8):402-9. doi:10.1016/ j.tips.2006.06.005
92. Canat X, Carayon P, Bouaboula M, Cahard D, Shire D, Roque C, et al. Distribution profile and properties of peripheral-type benzodiazepine receptors on human hemopoietic cells. Life Sci (1993) 52(1):107-18.
93. Canat X, Guillaumont A, Bouaboula M, Poinot-Chazel C, Derocq JM, Carayon P, et al. Peripheral benzodiazepine receptor modulation with phagocyte differentiation. Biochem Pharmacol (1993) 46(3):551-4. doi: 10.1016/0006-2952(93) 90535-5
94. Cagnin A, Kassiou M, Meikle SR, Banati RB. Positron emission tomography imaging of neuroinflammation. Neurotherapeutics (2007) 4(3):443-52. doi:10.1016/j.nurt.2007.04.006
95. van der Laken CJ, Elzinga EH, Kropholler MA, Molthoff CF, van der Heijden JW, Maruyama K, et al. Noninvasive imaging of macrophages in rheumatoid synovitis using 11C-(R)-PK11195 and positron emission tomography. Arthritis Rheum (2008) 58(11):3350-5. doi:10.1002/art.23955
96. Pugliese F, Gaemperli O, Kinderlerer AR, Lamare F, Shalhoub J, Davies AH, et al. Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography/computed tomography angiography. J Am Coll Cardiol (2010) 56(8):653-61. doi:10.1016/j.jacc.2010.02.063
97. Lamare F, Hinz R, Gaemperli O, Pugliese F, Mason JC, Spinks T, et al. Detection and quantification of large-vessel inflammation with 11C-(R)-PK11195 PET/CT. JNuclMed (2011) 52(1):33-9. doi:10.2967/jnumed.110.079038
98. Einstein AJ, Moser KW, Thompson RC, Cerqueira MD, Henzlova MJ. Radiation dose to patients from cardiac diagnostic imaging. Circulation (2007) 116(11):1290-305. doi:10.1161/CIRCULATIONAHA.107.688101
99. Gaemperli O, Shalhoub J, Owen DR, Lamare F, Johansson S, Fouladi N, et al. Imaging intraplaque inflammation in carotid atherosclerosis with 11CPK11195 positron emission tomography/computed tomography. Eur Heart J (2012) 33(15):1902-10. doi:10.1093/eurheartj/ehr367
100. Wang Y, Yue X, Kiesewetter DO, Niu G, Teng G, Chen X. PET imaging of neuroinflammation in a rat traumatic brain injury model with radiolabeled TSPO ligand DPA-714. Eur J Nucl Med Mol Imaging (2014) 41(7):1440-9. doi:10.1007/s00259-014-2727-5
101. Raman SV, AnejaA, JarjourWN. CMRin inflammatory vasculitis. J Cardiovasc MagnReson (2012) 14:82. doi:10.1186/1532-429X-14-82
102. Mavrogeni S, Cantini F, Pohost GM. Systemic vasculitis: an underestimated cause of heart failure - assessment by cardiovascular magnetic resonance. Rev Cardiovasc Med (2013) 14(1):49-55.
103. Simonetti OP, Finn JP, White RD, Laub G, Henry DA. "Black blood" T2-weighted inversion-recovery MR imaging of the heart. Radiology (1996) 199(1):49-57.
104. Hartung MP, Grist TM, Francois CJ. Magnetic resonance angiography: current status and future directions. J Cardiovasc Magn Reson (2011) 13:19. doi:10.1186/1532-429X-13-19
105. Piccini D, Monney P, Sierro C, Coppo S, Bonanno G, van Heeswijk RB, et al. Respiratory self-navigated postcontrast whole-heart coronary MR angiography: initial experience in patients. Radiology (2014) 270(2):378-86. doi:10. 1148/radiol.13132045
106. Mavrogeni S, Papadopoulos G, Douskou M, Kaklis S, Seimenis I, Baras P, et al. Magnetic resonance angiography is equivalent to X-ray coronary angiography for the evaluation of coronary arteries in Kawasaki disease. J Am Coll Cardiol (2004) 43(4):649-52. doi:10.1016/j.jacc.2003.08.052
107. Mavrogeni S, Bratis K, Karanasios E, Georgakopoulos D, Kaklis S, Varlamis G, et al. CMR evaluation of cardiac involvement during the convalescence of Kawasaki disease. JACC Cardiovasc Imaging (2011) 4(10): 1140- 1. doi:10.1016/j.jcmg.2011.04.021
108. Roghi A, Pedrotti P, Milazzo A, Vignati G, Martinelli L, Paino R, et al. Acute myocardial infarction and cardiac arrest in atypical Takayasu aortitis in a young girl: unusual diagnostic role of cardiac magnetic resonance imaging in emergency setting. Circulation (2010) 121(14):e370-5. doi:10.1161/CIR. 0b013e3181dab9ee
109. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, et al. Takayasu arteritis. Ann Intern Med (1994) 120(11):919-29. doi:10.7326/0003-4819-120-11-199406010-00004
110. Lagneau P, Michel JB, Vuong PN. Surgical treatment of Takayasu's disease. Ann Surg (1987) 205(2):157-66. doi:10.1097/00000658-198702000-00010
111. Hoffman GS, Ahmed AE. Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). IntJ Cardiol (1998) 66(Suppl 1):S191-4; discussion S5. doi:10.1016/S0167-5273(98)00181-8
112. Bonacina F, Baragetti A, Catapano AL, Norata GD. Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases. Mediators Inflamm (2013) 2013:725102. doi:10.1155/2013/725102
113. Dagna L, Salvo F, Tiraboschi M, Bozzolo EP, Franchini S, Doglioni C, et al. Pentraxin-3 as a marker of disease activity in Takayasu arteritis. Ann Intern Med (2011) 155(7):425-33. doi:10.7326/0003-4819-155-7-201110040-00005
114. Ishihara T, Haraguchi G, Kamiishi T, Tezuka D, Inagaki H, Isobe M. Sensitive assessment of activity of Takayasu's arteritis by pentraxin3, a new biomarker. JAm Coll Cardiol (2011) 57(16):1712-3. doi:10.1016/j.jacc.2010.10.058
115. Ishihara T, Haraguchi G, Tezuka D, Kamiishi T, Inagaki H, Isobe M. Diagnosis and assessment of Takayasu arteritis by multiple biomarkers. Circ J (2013) 77(2):477-83.doi:10.1253/circj.CJ-12-0131
116. Schmidt WA, Moll A, Seifert A, Schicke B, Gromnica-Ihle E, Krause A. Prognosis of large-vessel giant cell arteritis. Rheumatology (2008) 47(9): 1406-8. doi:10.1093/rheumatology/ken258
117. Hauenstein C, Reinhard M, Geiger J, Markl M, Hetzel A, Treszl A, et al. Effects of early corticosteroid treatment on magnetic resonance imaging and ultrasonography findings in giant cell arteritis. Rheumatology (2012) 51(11):1999-2003. doi:10.1093/rheumatology/kes153
118. Park MC, Lee SW, Park YB, Chung NS, Lee SK. Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol (2005) 34(4):284-92. doi: 10.1080/03009740510026526
119. Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum (2007) 56(3):1000-9. doi:10.1002/art.22404
120. Salvarani C, Silingardi M, Ghirarduzzi A, Lo Scocco G, Macchioni P, Bajocchi G, et al. Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis? Ann Intern Med (2002) 137(4):232-8. doi:10.7326/0003-4819-137-4-200208200-00006
121. Seth S, Goyal NK, Jagia P, Gulati G, Karthikeyan G, Sharma S, et al. Carotid intima-medial thickness as a marker of disease activity in Takayasu's arteritis. IntJ Cardiol (2006) 108(3):385-90.
122. Meller J, Sahlmann CO, Scheel AK. 18F-FDG PET and PET/CT in fever of unknown origin. JNucl Med (2007) 48(1):35-45.
123. Janssen SP, Comans EH, Voskuyl AE, Wisselink W, Smulders YM. Giant cell arteritis: heterogeneity in clinical presentation and imaging results. J Vasc Surg (2008) 48(4):1025-31. doi:10.1016/j.jvs.2008.04.054
124. Arnaud L, Haroche J, Malek Z, Archambaud F, Gambotti L, Grimon G, et al. Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis? Arthritis Rheum (2009) 60(4):1193-200. doi:10.1002/art.24416
125. Steeds RP, Mohiaddin R. Takayasu arteritis: role of cardiovascular magnetic imaging. Int J Cardiol (2006) 109(1):1-6. doi:10.1016/j.ijcard.2004.09.023
126. Andrews J, Mason JC. Takayasu's arteritis - recent advances in imaging offer promise. Rheumatology (2007) 46(1):6-15. doi:10.1093/rheumatology/kel323
127. Dasgupta B. Concise guidance: diagnosis and management of giant cell arteritis. ClinMed (2010) 10(4):381-6. doi:10.7861/clinmedicine.10-3-270
128. Japanese Circulation Society. Guideline for management of vasculitis syndrome (JCS 2008). Japanese Circulation Society. CircJ (2011) 75(2):474-503. doi:10.1253/circj.CJ-88-0007
129. Dasgupta B, Borg FA, Hassan N, Alexander L, Barraclough K, Bourke B, et al. BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology (2010) 49(8):1594-7. doi:10.1093/rheumatology/keq039a
130. Direskeneli H, Aydin SZ, Merkel PA. Assessment of disease activity and progression in Takayasu's arteritis. Clin Exp Rheumatol (2011) 29(1 Suppl 64):S86-91.
131. Borg FA, Dasgupta B. Treatment and outcomes of large vessel arteritis. Best Pract Res Clin Rheumatol (2009) 23(3):325-37. doi:10.1016/j.berh.2009. 04.001
132. Tezuka D, Haraguchi G, Ishihara T, Ohigashi H, Inagaki H, Suzuki J, et al. Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences. JACC Cardiovasc Imaging (2012) 5(4):422-9. doi:10.1016/j.jcmg.2012.01.013
133. Comarmond C, Cluzel P, Toledano D, Costedoat-Chalumeau N, Isnard R, Gaudric J, et al. Findings of cardiac magnetic resonance imaging in asymptomatic myocardial ischemic disease in Takayasu arteritis. Am J Cardiol (2014) 113(5):881-7.doi:10.1016/j.amjcard.2013.11.045
134. Li D, Lin J, Yan F. Detecting disease extent and activity of Takayasu arteritis using whole-body magnetic resonance angiography and vessel wall imaging as a 1-stop solution. J Comput Assist Tomogr (2011) 35(4):468-74. doi:10.1097/ RCT.0b013e318222d698
135. Koenigkam-Santos M, SharmaP, Kalb B, Oshinski JN,Weyand CM, GoronzyJJ, et al. Magnetic resonance angiography in extracranial giant cell arteritis. J Clin Rheumatol (2011) 17(6):306-10. doi:10.1097/RHU.0b013e31822acec6
136. Mavrogeni S, Karabela G, Gialafos E, Stavropoulos E, Spiliotis G, Katsifis G, et al. Cardiac involvement in ANCA (+) and ANCA (-) Churg-Strauss syndrome evaluated by cardiovascular magnetic resonance. Inflamm Allergy Drug Targets (2013) 12(5):322-7.